J And J Consumer Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for J AND J CONSUMER INC, and what generic alternatives to J AND J CONSUMER INC drugs are available?
J AND J CONSUMER INC has twenty-nine approved drugs.
There are three US patents protecting J AND J CONSUMER INC drugs.
There are forty-three patent family members on J AND J CONSUMER INC drugs in thirty-five countries and thirty-eight supplementary protection certificates in thirteen countries.
Summary for J And J Consumer Inc
International Patents: | 43 |
US Patents: | 3 |
Tradenames: | 23 |
Ingredients: | 11 |
NDAs: | 29 |
Drugs and US Patents for J And J Consumer Inc
Expired US Patents for J And J Consumer Inc
Paragraph IV (Patent) Challenges for J AND J CONSUMER INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Syrup | 5 mg/5 mL | ➤ Subscribe | 2007-03-19 |
➤ Subscribe | Chewable Tablets | 800 mg/ 10 mg/ 165 mg (OTC) | ➤ Subscribe | 2004-11-01 |
➤ Subscribe | Chewable Tablets | 5 mg and 10 mg | ➤ Subscribe | 2005-03-25 |
International Patents for J And J Consumer Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hungary | 229803 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 03002098 | See Plans and Pricing |
South Korea | 20040007756 | See Plans and Pricing |
Costa Rica | 7198 | See Plans and Pricing |
Romania | 122476 | See Plans and Pricing |
Slovakia | 287645 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for J And J Consumer Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | 1990003-4 | Sweden | See Plans and Pricing | PRODUCT NAME: PATRIOMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179 20170721 |
2435024 | 2021C/518 | Belgium | See Plans and Pricing | PRODUCT NAME: UNE COMBINAISON DE FORMOTEROL (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), GLYCOPYRROLATE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET BUDESONIDE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1498 20201210 |
0428296 | SPC/GB98/013 | United Kingdom | See Plans and Pricing | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
2957286 | 122018000145 | Germany | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
0720599 | CR 2014 00050 | Denmark | See Plans and Pricing | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
0247633 | 62/1997 | Austria | See Plans and Pricing | PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.